ISOPAQUE CYSTO 100 MG Ireland - English - HPRA (Health Products Regulatory Authority)

isopaque cysto 100 mg

nycomed (uk) limited - sodium metrizoate calcium metrizoate magnesium metrizoate meglumine metrizoate - i millilitre

VISIPAQUE iodixanol 110g/200mL (550mg/mL) injection bag Australia - English - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 110g/200ml (550mg/ml) injection bag

ge healthcare australia pty ltd - iodixanol, quantity: 550 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium calcium edetate; sodium chloride; water for injections; sodium hydroxide; calcium chloride dihydrate; trometamol - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

VISIPAQUE iodixanol 55g/100mL (550mg/mL) injection bag Australia - English - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 55g/100ml (550mg/ml) injection bag

ge healthcare australia pty ltd - iodixanol, quantity: 550 mg/ml - injection, solution - excipient ingredients: water for injections; calcium chloride dihydrate; sodium calcium edetate; trometamol; sodium hydroxide; hydrochloric acid; sodium chloride - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

VISIPAQUE iodixanol 110g/200mL (550g/mL) injection bottle Australia - English - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 110g/200ml (550g/ml) injection bottle

ge healthcare australia pty ltd - iodixanol, quantity: 550 mg/ml - injection, solution - excipient ingredients: sodium calcium edetate; calcium chloride dihydrate; trometamol; water for injections; sodium chloride; sodium hydroxide; hydrochloric acid - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.